This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Urine screening for amfetamine (amphetamine)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Approximate duration of detectability of selected drugs in the urine (1,2)

Substance

Duration of Detectability

amfetamines (amphetamines)

48 hours

methamphetamine

48 hours

barbiturates (1)

short-acting

intermediate-acting

long-acting

 

24 hours

48-72 hours

7 days or more

benzodiazepines (2)

- ultra-short-acting (half-life 2 hours) e.g. midazolam

- short-acting (half-life 2-6 hours) e.g. triazolam

- intermediate acting (half-life 6-24 hours) e.g. temazepam, chlordiazepoxide

- long-acting (half-life 24 hours) e.g. diazepam/nitrazepam

 

12 hours

24 hours

2-5 days

7 days or more

Cocaine Metabolites

2-3 days

Methadone (maintenance dosing)

7-9 days (approximate)

Codeine/Propoxyphene/Morphine

(heroin is detected in the urine as the metabolite morphine)

48 hours

norpropoxyphene (1)

6-48 hours

cannabinoids (marijuana)

- single use

- moderate use ( 3 times per week)

- heavy use (daily)

- chronic heavy use

 

3-4 days

5-6 days

20 days

up to 45 days

methaqualone (1)

7 days or more

phencyclidine (PCP) (1)

8 days (approximate)

Buprenorphine and metabolites

8 days

Reference:

  • (1) adapted from Department of Health (1999). Drug Misuse and Dependence - Guidelines on Clinical Management, 25.
  • (2) Department of Health (2007). Drug misuse and dependence: UK guidelines on clinical management, 30.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.